2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
US-12565476-B2 · Mar 3, 2026 · US
This page is not indexed by search engines while we improve data quality.
Buckl Andreas patents
Buckl Andreas is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Buckl Andreas |
| Total patents | 40 |
| First publication | Jul 11, 2019 |
| Latest publication | Mar 3, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
US-12365688-B2 · Jul 22, 2025 · US
Bicyclic heteroaryl compounds and uses thereof
US-12258366-B2 · Mar 25, 2025 · US
Ras inhibitors
US-12202845-B2 · Jan 21, 2025 · US
Bicyclic compounds as allosteric shp2 inhibitors
US-2024199616-A1 · Jun 20, 2024 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
US-2024116878-A1 · Apr 11, 2024 · US
Polycyclic compounds as allosteric shp2 inhibitors
US-2024101577-A1 · Mar 28, 2024 · US
Pyridine compounds as allosteric shp2 inhibitors
US-2024092795-A1 · Mar 21, 2024 · US
Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
US-2024067636-A1 · Feb 29, 2024 · US
Ras inhibitors
US-2023374035-A1 · Nov 23, 2023 · US
Recent patents
Latest publications not already listed above.
Bicyclic heteroaryl compounds and uses thereof
US-2023365605-A1 · Nov 16, 2023 · US
Ras inhibitors
US-2023303591-A1 · Sep 28, 2023 · US
Ras inhibitors
US-11739074-B2 · Aug 29, 2023 · US
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
US-11739093-B2 · Aug 29, 2023 · US
Ras inhibitors
US-2023234929-A1 · Jul 27, 2023 · US
Ras inhibitors
US-2023226186-A1 · Jul 20, 2023 · US
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
US-11702411-B2 · Jul 18, 2023 · US
Ras inhibitors
US-11690915-B2 · Jul 4, 2023 · US
Polycyclic compounds as allosteric SHP2 inhibitors
US-11673901-B2 · Jun 13, 2023 · US
Pyridine compounds as allosteric SHP2 inhibitors
US-11673896-B2 · Jun 13, 2023 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
US-11661401-B2 · May 30, 2023 · US
Bicyclic heteroaryl compounds and uses thereof
US-2023148450-A9 · May 11, 2023 · US
Covalent ras inhibitors and uses thereof
US-2023100838-A1 · Mar 30, 2023 · US
Bicyclic heterocyclyl compounds and uses thereof
US-2023096028-A1 · Mar 30, 2023 · US
Ras inhibitors
US-11566007-B2 · Jan 31, 2023 · US
Ras inhibitors
US-2022396589-A1 · Dec 15, 2022 · US
Bicyclic heteroaryl compounds and uses thereof
US-2022135584-A1 · May 5, 2022 · US
Ras inhibitors
US-2022105185-A1 · Apr 7, 2022 · US
Bicyclic heteroaryl compounds and uses thereof
US-11168102-B1 · Nov 9, 2021 · US
Bicyclic heteroaryl compounds and uses thereof
US-2021139517-A1 · May 13, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Revolution Medicines Inc | 40 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 40 |
| C07D519/00 | 26 |
| C07D471/04 | 21 |
| C07D487/04 | 18 |
| C07D491/107 | 17 |